Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
11.8%
% of XBI's 136 holdings also in ARKG
48.5%
% of ARKG's 35 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus ARKG)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XBI |
Weight in ARKG |
Overlap | |
---|---|---|---|---|
NATERA INC | 3.5% | 5.0% | 3.5% | |
AMGEN INC | 2.2% | 1.6% | 1.6% | |
CRISPR THERAPEUTICS AG | 1.5% | 6.9% | 1.5% | |
IONIS PHARMACEUTICALS, INC. | 1.2% | 3.9% | 1.2% | |
VERTEX PHARMACEUTICALS INC | 2.6% | 1.0% | 1.0% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to ARKG
GILEAD SCIENCES INC | 3.0% | |
UNITED THERAPEUTICS CORP | 2.9% | |
ADVENTRX PHARMACEUTICALS INC | 2.8% | |
NEUROCRINE BIOSCIENCES INC | 2.8% | |
SAREPTA THERAPEUTICS INC | 2.7% | |
INSMED INC | 2.6% | |
ALNYLAM PHARMACEUTICALS INC | 2.5% | |
ABBVIE INC | 2.4% | |
MADRIGAL PHARMACEUTICALS, INC. | 2.2% | |
BIOMARIN PHARMACEUTICAL INC | 2.1% |
XBI Underweight Relative to ARKG
TWIST BIOSCIENCE CORP. | -8.2% | |
RECURSION PHARMACEUTICALS, INC CLASS | -6.5% | |
ADAPTIVE BIOTECHNOLOGIES CORP. | -5.6% | |
CRISPR THERAPEUTICS AG | -5.4% | |
CAREDX, INC. | -4.7% | |
VERACYTE INC | -4.6% | |
GUARDANT HEALTH, INC. | -4.5% | |
SCHRODINGER, INC. | -4.1% | |
BEAM THERAPEUTICS, INC. | -3.5% | |
10X GENOMICS INC CLASS A | -3.4% |